Allergan USA, Inc. v. Imprimis Pharmaceuticals, Inc.

Original Case: 8:17-cv-01551

Ninth Circuit U.S. Court of Appeals
Case #: 0:19-cv-55756
Typecivil / private
Nature of Suit890 Other Statutes - Other Statutory Actions
Case Filed:Jul 01, 2019
Terminated:Oct 03, 2019
Last checked: Saturday Oct 05, 2019 1:41 AM PDT
Defendant - Appellee
IMPRIMIS PHARMACEUTICALS, INC.
Represented By
Philip K. Lem
Ogletree Deakins
contact info
David Alexander Grant
Payne & Fears LLP
contact info
Carl Alan Roth
Browne George Ross LLP
contact info
Keith J. Wesley
Browne George Ross LLP
contact info
Daniel L. Rasmussen
Payne & Fears LLP
contact info
Plaintiff - Appellant
ALLERGAN USA, INC.
Represented By
Joseph Nicholas Akrotirianakis
King and Spalding LLP
contact info
Jeffrey S. Bucholtz
King & Spalding LLP
contact info


Docket last updated: 10/05/2019 1:33 AM PDT
Monday, July 01, 2019
1 1 DOCKETED CAUSE AND ENTERED APPEARANCES OF COUNSEL. SEND MQ: Yes. The schedule is set as follows: Mediation Questionnaire due on 07/08/2019. Transcript ordered by 07/29/2019. Transcript due 08/26/2019. Appellant Allergan USA, Inc. opening brief due 10/07/2019. Appellee Imprimis Pharmaceuticals, Inc. answering brief due 11/07/2019. Appellant's optional reply brief is due 21 days after service of the answering brief. [11350771] (RT) [Entered: 07/01/2019 02:42 PM]
Related: [-]
Att: 1 3 pgs Docketing Letter
Att: 2 1 pgs Mediation Letter
Att: 3 22 pgs Case Opening Packet